scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1103463128 |
P356 | DOI | 10.1186/S12885-018-4289-6 |
P932 | PMC publication ID | 5909228 |
P698 | PubMed publication ID | 29673336 |
P50 | author | Veronika Seebacher | Q88410766 |
P2093 | author name string | Nicole Concin | |
Stephan Polterauer | |||
Alexander Reinthaller | |||
Heinz Koelbl | |||
Astrid Berger | |||
Regina Achleitner | |||
P2860 | cites work | ABO blood group and incidence of epithelial ovarian cancer | Q24599521 |
Global cancer statistics, 2012 | Q27860501 | ||
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer | Q33783766 | ||
The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. | Q53574858 | ||
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer. | Q54448028 | ||
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer | Q60685706 | ||
Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancer | Q67680941 | ||
Expression of A, B, and H blood group antigens in epithelial ovarian cancer: relationship to tumor grade and patient survival | Q71215855 | ||
Blood groups of the ABO system and survival rate in gynecologic tumors | Q71945863 | ||
Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancy | Q74428806 | ||
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial | Q83287534 | ||
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma | Q84947425 | ||
FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology | Q33922334 | ||
ABH and Lewis histo-blood group antigens in cancer | Q34215529 | ||
Red blood cell blood group antigens: structure and function | Q34311979 | ||
AB0 blood group and prognosis in patients with pancreatic cancer | Q34354138 | ||
ABO blood groups and risk of cancer: a systematic review and meta-analysis | Q34662761 | ||
The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors | Q35663610 | ||
Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status | Q35822048 | ||
Prognostic Impact of ABO Blood Group on the Survival in Patients with Ovarian Cancer | Q35978580 | ||
The Rh protein family: gene evolution, membrane biology, and disease association | Q37642606 | ||
A brief history of human blood groups | Q41208027 | ||
Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. | Q41345298 | ||
Human epithelial ovarian cancer allelotype. | Q53480313 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 447 | |
P577 | publication date | 2018-04-19 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study | |
P478 | volume | 18 |
Q64986685 | AB0 Blood Group and Ovarian Cancer Survival. | cites work | P2860 |
Search more.